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Discrete microenvironments within the bone marrow are thought to regulate the
production ofeight types ofblood cells through direct cell contact-mediated inter-
actions and elaboration ofcytokines. Stromal cells representing at least onecompo-
nent of the microenvironment for myeloid and lymphoid cell formation are now
available as cloned cell lines that can be manipulated and studied in long-term cul-
tures (1-3). It is clear that stromal cells can make a number ofregulatory cytokines
including macrophage CSF (M-CSF),' granulocyte/macrophage CSF (GM-CSF),
IL-6, and IL-7 (3). However, little is known about how close physical proximity is
maintained between stromal cells and the precursor cells they influence. Stromal
cells can express several known adhesion molecules in culture, including N-CAM
and N-cadherin, and lymphoid and myeloid progenitors bear LFA-1 and MEL-14
molecules (4-7). However, there is as yet no evidence that these have functional
significance.
Serological identity has recently been found for a group ofwidely distributed cell
surface glycoproteins that have been implicated in lymphocyte homing, as well as
interaction between cells and the extracellular matrix (8-10). Originally known as
Pgp-1/Ly-24 in the mouse and classified as CD44 in humans, these molecules have
alsobeen extensively studied as markersofTlymphocyte subsets and theirprecursors
(8, 9, 11, 12). We prepared a panel ofmAbs that recognize a cloned murine stromal
cell line and selected fourthatmightbe ofparticular interest with an adhesion assay.
These were then found to completely block production of lymphoid and myeloid
cellswhen added tolong-term bone marrowcultures (LTBMC). Sequential immu-
noprecipitation and other comparisonsindicate that thesenewantibodies recognize
epitopes on Pgp-1/CD44. Moreover, a previously described antibody to Pgp-1 (13)
is also inhibitory, through a mechanism that does not involve direct toxicity to pro-
genitor cells. These findings suggest that components ofthe Pgp-1/CD44 complex
may be critically important for cell recognition functions necessary for lympho-
hemopoiesis within bone marrow.
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Materials and Methods
Animals.
￿
BALB/c, SLID mice and LOU/MN rats were bred in our Animal Resources
Center. BALB/c mice were used for LTBMC, immunofluorescence, and colony-forming cell
assays at 6-10 wk of age.
Antibodies and Cell Lines.
￿
The rat mAb IM 7.8.1 (anti-Pgp-1) was kindly provided by Dr.
Ian S. Trowbridge (The Salk Institute, San Diego, CA) (13). The rat mAb M17/4.2 (anti-
LEA-1) and MEL-14 (anti-peripheral lymph node homing receptor) were obtained via the
American Type Culture Collection (ATCC, Rockville, MD). Rat mAb 14.8 against Ly-
522o/CD45R was established in this laboratory (14). KM 201, KM 703, and KMC 8 mAbs
were produced by fusion of the hybridoma line Sp2/0 (15) with spleen cells from LOU/MN
rats immunized with the bone marrow-derived stromal cell clone, BMS2 (16). BMS2 was
established in our laboratory from (C57BL/6J x DBA/2J)F1 female mice (16). BM-2 is an
anti-2,4,6TNP mAb-producing B cell hybridoma derived from fusion ofP3X63Ag8U.1 my-
eloma cells and BALB/c spleen cells immunized with TNP-Ficoll, and a protocol was used
to select for cells with marrow homing ability. That is, hybrids were injected intravenously
and recovered from the bone marrow 24 h later. This B lineage cell line adhered well to the
BMS2 stromal cell clone and was used for selecting the monoclonal antibodies that are detailed
in this report. Screening and selection of four new hybridomas with similar specificity used
the cell adhesion assay detailed below. All rat mAbs were semipurified from ascitic fluid of
SLID mice by ABx column chromatography (J. T. Baker Inc., Philipsburg, NJ). Most batches
had a single predominant band on SDS-PAGE analysis.
Cell Adhesion Assay.
￿
BM-2 cells were radiolabeled by incubation of 2 x 10' cells in 1 ml
complete medium with 100 uCi of Nat "CrO4 for 1 h at 37°C and washed three times in
complete medium. The labeled cells (2 x 105/well) were then added with or without anti-
bodies to 24-well plates (Corning Glass Works, Corning, NY) that contained adherent BMS2
stromal cells plated (2 x 104/well) the day before. The plates were incubated for 1 h at 37°C,
and unbound cellswere removed by three cycles ofwashing in prewarmed complete medium
with vigorous agitation on a Minishaker (Dynatech Laboratories, Inc., Alexandria, VA) for
30 s before each aspiration. Bound cells were solubilized with 0.1 N NaOH, 1% NP-40 (Sigma
Chemical Co., St. Louis, MO) and the "Cr was counted with a gamma counter (Beckman
Instruments, Fullerton, CA) . Percentages of bound cells were determined by dividing cpm
from bound cells by input cell-associated cpm, from which spontaneous release was subtracted
and multiplied by 100%.
LongTerm Bone Marrow Cultures.
￿
LTBMC of B lineage cells were prepared according to
Whitlock and Witte (Whitlock-White culture) (2). Briefly, pooled cells from femora and tibiae
were placed into a 25-cm' flask (5-6 x 106 cells; Corning Glass Works). The culture medium
consisted of RPMI 1640 (Gibco Laboratories, Grand Island, NY), 2 MM L-glutamine, 100
U/ml penicillin, 100 l~g/ml streptomycin, 5 x 10-5 M 2-ME, and 5% FCS (Lot No. 1111794;
HyClone Laboratories, Logan, UT). LTBMC of myeloid cells were initiated and maintained
by the methods described by Dexter et al. (Dexter culture) (1). Briefly, 10-13 x 106 bone
marrow cells were cultured in 25-cm' flasks. The culture medium consisted of a-MEM
(Gibco Laboratories; without ribonucleosides and deoxyribonucleosides), penicillin, strep-
tomycin, 10' M hydrocortisone sodium salt, and 20% horse sera (Gibco). These flasks were
incubated in 5% C02 at 33°C. In both kinds of LTBMC, half of the medium (3 ml) was
replaced with fresh medium weekly. The antibodies (5 Fog/ml) were added at the beginning
of culture and at every feeding.
Colonyforming Assays.
￿
The GM progenitor (CFU-c) assay was performed as in our previous
studies (17). Proliferation was stimulated with 10 times concentrated WEHI-3 or L cell-con-
ditioned medium (LCCM). Bone marrow cells (5 x 104) were plated in 1-ml dishes (Miles
Laboratories Research, Elkhart, IN). A cloning assay for pre-B cells was used as recently
described (18) with 500 U/ml of murine rIL-7 (donated by Dr. A. Namen, Immunex Corp.,
Seattle, WA).
Immunofluorescence Analyses.
￿
Cells from several lymphoid organs or harvested from cultures
were incubated for 20 min on ice with tissue culture supernatants containing antibodies in
RPMI 1640 supplemented with 5% FCS and 0.1% sodium azide. This was followed by two
washes and incubation with FITC-conjugated mouse anti-rat K (MAR 18.5) for an addi-MIYAKE ET AL.
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tional 20 min. Propidium iodide (Sigma Chemical Co.) was added during the second incuba-
tion to detect dead cells. Labeled cells were then analyzed on a EPICS V flow cytometer
(Coulter Electronics Inc., Hialeah, FL).
Cell Surface Labeling andImmunoprecipitation.
￿
Cells were surface-labeled by an N-hydroxy-
succinimidobiotin (NHS-biotin) procedure (19). Briefly, after three washes in HBSS, cells
were suspended in HBSS (pH 8.0 adjusted by 0.1 M sodium bicarbonate/carbonate, pH 8.7)
at a concentration of3 x 107/ml. NHS-biotin (Pierce Chemical Co., Rockford, IL) dissolved
in DMSO (50 mg/ml) was added to cell suspensions in such that the final concentration of
NHS-biotin was 2 mg/ml. After a 40-min incubation on ice with occasional shaking, cells
were washed three times in chilled RPMI 1640. The cell lysates were prepared by detergent
lysis at a concentration of 5 x 10'/ml for 15 min on ice in a lysis buffer containing 10 mM
Tris-HCI, 0.15 M NaCl, I% NP-40, 50 mM Iodoacetamide (Sigma Chemical Co.), 1 mM
PMSF (Sigma Chemical Co.), 5 mM EDTA, and 0.1 % sodium azide, pH 7.5. After centrifu-
gation,the lysates were precleared three times with 50 pl of Sepharose 4B conjugated with
goat anti-rat IgG (Zymed Laboratories, San Francisco, CA) that had been incubated with
either normal rat IgG, IM7.8.1, or KM201. The precleared lysates were added to 30 pl of
antibody-conjugated goat anti-rat IgG-Sepharose 4B. The mixtures were rotated for 60 min
at 4°C and then washed'three times with a buffer containing 10 mM Tris-HCI, 0.6 M NaCl,
pH 7.5. This was followed by three washes with a 10 mM Tris-HCI buffer, pH 8.8, containing
0.6 M NaCl, 0.5% SDS, and 0.05% NP-40. The absorbed proteins were released by boiling
for 5 min in a sample buffer containing 0.125 M Tris-HCI, 2% SDS, 10% glycerol, and 5%
2-ME, pH 6.8. SDS-PAGE was carried out on Laemmli 10% polyacrylamide gels.
BlottingandDeveloping
￿
After electrophoresis, the gels were equilibrated for 30 min in transfer
buffer (0.025 M Tris, 0.192 M glycine, and 20% methanol), and proteins were electrophoreti-
cally transferred to Immobilon P Transfer Membranes (Millipore Corp., Bedford, MA) by
blotting overnight at 20 mV in a Trans-Blot Cell (Bio-Rad Laboratories, Richmond, CA).
Transfer membranes were then soaked for 60 min in PBS containing 5% BSA, 3% gelatin,
0.05% Tween 20, and 0.2ojo thimerosal (Sigma Chemical Co.), followed by a 60-min incuba-
tion in PBS containing 0.1% avidin-horseradish peroxidase (Bio-Rad Laboratories), 1 % BSA,
and 0.05% Tween 20. After extensive washing in PBS with 0.05% Tween 20, membranes
were developed in PBS containing 20% methanol 0.6 mg/ml 4-chloro-l-Naphthol (Sigma
Chemical Co.), and 0.003% hydrogen peroxide.
Results
Production andSelection ofmAbs.
￿
A panel ofmAbs was prepared to a bone marrow-de-
rivedstromal cell clone (16). A screening procedure was then used to obtain reagents
that might detect antigens associated with cell recognition or adhesion functions.
Cellsfrom the BM-2 antiTNP-producing hybridoma line readily adhered to BMS2
stromal cells and were easily labeled with "Cr. A more complete description of BM-
2 cells and their derivation will be submitted elsewhere, but this line was originally
selected on the basis of its ability to home to the bone marrow in vivo (Miyake, K.,
unpublished observations). Of-250 hybrids that recognized the immunizing stromal
cell line in an initial screen by ELISA, only four inhibited in the adhesion assay
as demonstrated for one of them (KM 201) in Fig. 1. KMC 8 detects an antigen
that is also represented in high density on BM-2 and BMS2 cells, but had no effect
in the adhesion assay. It is shown as a representative negative control antibody. Simi-
larly, mAb 14.8 did not prevent binding ofBM-2 cells to stromal cells(datanot shown).
An anti-Pgp-1 antibody (IM 7.8.1) inhibited in the adhesion assay, but less effec-
tively than the new KM 201 mAb (data not shown).
Tissue Distribution and Similarity to Pglb-I.
￿
Immunofluorescence analyses with the
new mAbs revealed a relatively high density ofantigen on the immunizing stromal
cell clone, as well as on the B lineage hybridoma used for the adhesion assay (Fig.480
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FIGURE 1.
￿
Inhibition ofBlin-
eage cell adhesion to a cloned
stromal cell line by mAbs. Var-
ious concentrations of anti-
bodies were inoculated together
with 5 'Cr-labeled BM-2 cells
on monolayers of a cloned
stromal cell line (BMS2) in 24-
well culture plates. KMC 8 is
representative of hundreds of
mAbs that recognized the
BMS2 stromalcell line, butdid
not inhibit in this adhesion
assay. The results were calcu-
latedas detailed in theMaterials
and Methods andpresentedas
1 .0
￿
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￿
100.0
￿
means t SE oftriplicate wells.
Antibody Concentration (lcg/ml)
￿
Total inputcpm in this experi-
ment were 43,598/well.
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2). Nearly all of the nonadherent myeloid cells in Dexter-type, long-term cultures
were brightly stained, and lower but significant staining was observed on most of
the lymphoid cells harvested from Whitlock-Witte cultures (Fig. 2). With a more
sensitive second antibody, all of the lymphocytes had above background amounts
of this antigen (data not shown). Staining of normal bone marrow cells routinely
revealed high and low density populations and this pattern was strikingly similar
to published descriptions of Pgp-1 antibodies (13) . Indeed, direct comparison of the
Dexter
LogFluorescence Intensity
FIGURE 2.
￿
Recognition of B lineage cells, stromal cells, and nonadherent cells in LTBMC by
mAb KM 201. Cellswere stained and analyzed by flow cytometry as described in the Materials
andMethodsand the faint tracings represent staining when the primary antibody was omitted.
BMS2 cells were detached from culture dishes before analysis and typicallyexhibit a relatively
high level of background fluorescence.
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0.01 0.1mAb IM 7.8.1 to Pgp-1 with our new reagents revealed no significant differences
by flow cytometry with a variety of cell types (Figure 3).
Biochemical Identification of Pgp-1 Antigen.
￿
Formal proof that our new antibodies
detect epitopes on the Pgp-1 molecule wasobtained by sequential immunoprecipita-
tion. Identical size molecules were always precipitated from lysates of biotinylated
BM2 cells with IM 7.8.1 and our antibodies (Fig. 4 and data not shown). With re-
duced samples run on 7.5% SDS-acrylamide gels, one major band corresponding
to 80-95 kD was routinely observed, and a higher molecular mass species (-200
kD) was detectable in some experiments. Both of these species have been described
with antibodies to Pgp-1 and the larger one is thought to be associated with chon-
droitin sulfate (20). On nonreducing gels, migration of the smaller species ranged
from 68 to 88 kD (not shown). The presence of an intramolecular disulfide bond
may account for this mobility difference as suggested by studies of human Pgp-1
(21). Preclearing of the lysates with antibody-coated beads revealed complete iden-
tity between themolecules recognized by IM 7.8.1 andourKM 201 antibodies (Fig. 4).
Inhibition ofLympho-hemopoiesis by Antibodies to Pgp-1.
￿
LTBMC provide a means
to test the functional significance of cells and molecules derived from bone marrow.
Theoriginal Dexter culture system permits extended propagation of neutrophil gran-
ulocytes, macrophages, and multipotential stem cells(1). Blineagelymphocytesselec-
tively grow under the modified conditions developed by Whitlock and Witte (2).
In three independent experiments, inclusion ofmAbs to Pgp-1 completely prevented
theproduction of nonadherent cells in both types ofcultures (Figs. 5 and6). Marked
KM 201
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FIGURE 3.
￿
Tissue representation of antigens detected by mAbs KM201 andanti-Pgp-1 . In this
comparison, various freshly isolated tissues were stained with KM 201, or apreviously described
antibody to Pgp-1/CD44 (IM 7.8.1), and analyzed by flow cytometry.482
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agglutination of Dexter cultured cells occurred with amAb to the MEL-14 homing
receptor and expansion ofnonadherent cell numbers was apparently delayedby ad-
dition ofM 17/4.2 antibody to the LFA-1 adhesion molecule (22, 23) . However, Dexter
cultures containingMEL-14 and LFA-1 antibodies were eventually productive . Like-
wise, these antibodies had no effect when added to Whitlock-Witte cultures (Fig .
6 and data not shown) . Similarly, an antibody (14.8) to the Ly-522o/CD45R common
leukocyte antigen (14) did not influence growth of cells in either type of long-term
culture (Figure 6 and data not shown) . Suppressive IM 7 .8.1 and nonsuppressive
14.8 antibodies were of the same isotype (IgG2b) . Another new antibody to Pgp-1
(KM 703) was also suppressive (datanot shown) and it is ofthe same IgG2asubclass
as MEL-14 andM 17/4 .2 (LFA-1) antibodies, which were without effect . The KM
201 antibody shown here is an IgG1 . Therefore, inhibition of growth in long-term
cultures is not dependent on a particular Ig isotype . Antibodies to various Pgp-1
epitopes could differ with respect to the efficiency with which they block lympho-
FIGURE 5 .
￿
Inhibition of my-
elopoiesis in long-term cultures
by addition ofantibodies to Pgp-
1/CD44 . Bone marrow cells
(10-12 x 10 6 cells/flask) were
inoculated with the indicated
semipurified antibodies (5 kg/
ml) and maintained in culture
under Dexter conditions. Non-
adherent cells recovered in the
medium removed atweekly feed-
ings were counted and used to
calculate the total number of
nonadherent cells per flask .The
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￿
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data are presented as means ±
Weeks of Culture
￿
SE for five replicate cultures .
FIGURE 4 .
￿
Sequential immunoprecipitation of
surface membrane glycoproteins with KM 201
and anti-Pgp-1 antibodies. BM-2 hybridomacells
were biotinylated with NHS-biotin and extracts
were prepared . These were precleared with beads
bearing normal rat IgG and then beads coated
with normal rat IgG (lane 1),KM 201 (lane 2),
or anti-Pgp-1 (IM 7.8.1, lane 3) . Some samples
were precleared withKM 201, and immunopre-
cipitated with KM 201 (lane 4) or IM 7.8 .1 (lane
5). Others were precleared withIM 7.8 .1 andim-
munoprecipitated with KM 201 (lane 6), orIM
7 .8 .1 (lane 7) . Specifically boundmoleculeswere
resolved by electrophoresis on 10% SDS-poly-
acrylamide gels under reducing conditions and
revealed by exposure toan avidin-peroxidase con-
jugate and development .
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FIGURE 6. Inhibition of lym-
phopoiesis in long-term cultures by
addition of antibodies to Pgp-
1/CD44. Bone marrow cells (6-8 x
106 cells/flask) were inoculated and
maintained with the indicated
antibodies (5 Wg/ml) under Whit-
lock-Witte conditions. The data rep-
resent means t SE cells in six repli-
cate flasks.
hemopoiesis. Greater than 1 /.tg/ml was sufficient to achieve suppression with some
of the reagents, but a fraction of the cultures were productive with other antibodies
at this lower concentration (data not shown). In most experiments, 5 /Ag of anti-
body/mlwasadded to insure saturating concentrations and this wascompletely sup-
pressive with all of the anti-Pgp-1 antibodies that were tested.
E,fiects on Adherent Layer Formation and Progenitor Proliferation.
￿
Although lympho-
hemopoiesis was totally prevented by antibodies to Pgp-1, the adherent layers of
LTBMC were not markedly influenced in terms of morphology (Fig. 7). Treated
cultures contained fat cells and macrophages, as well as adherent cells with the ap-
pearance of stromal cells. The possibility that the antibodies might interfere with
replication of myeloid and lymphoid progenitor cells wasinvestigated with semisolid
agar cloning procedures. Up to five times the concentration of antibodies used in
long-term cultures had no influence on proliferation induced by IL-7 (pre-B cells)
or two sources of CSF (myeloid progenitors) (Table I). These findings indicate that
the antibodies to Pgp-1 are not directly toxic to hemopoietic cells or to cells that
comprise the microenvironment required for their growth.
Discussion
A variety of cell surface glycoproteins may facilitate close interactions between
hemopoietic progenitors and the microenvironment that regulates their prolifera-
tion and differentiation. Previous studies have implicated Pgp-1/CD44 in adhesion
and cell recognition functions in peripheral lymphoid tissues. We now provide evi-
dence with long-term cultures and mAbs that this molecule may also be critical to
the development of cells in two hemopoietic lineages. Addition of mAbs to long-
term cultures may provide an importantexperimental approach fortestingthe func-
tional significance of other cell surface glycoproteins.
Pgp-1 was first identified as amajor polymorphic surfaceglycoprotein on cultured
murine fibroblasts and peritoneal exudate cells (24, 25). Later studies revealed that
it is present on hemopoietic cells, and particularly abundant on myeloid cells and
activated lymphocytes (13, 26). The human equivalent (CD44) was identified and
shown to carry epitopes previously designated as p85, T lymphocyte-granulo-
cyte-brain antigen, human medullary thymocyte antigen, and an erythrocyte an-484
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FIGURE 7 .
￿
Effect of mAbs to Pgp-1/CD44 on the morphology ofLTBMC. Phase contrast pho-
tomicrographs were prepared of Dexter (A and B) and Whitlock-Witte (C and D) cultures after
7-8 wk ofcontinuous antibody treatment (B and D) . Control cultures received medium alone
(A and C) . Original magnifications, x250 .
tigen (9, 27) . Pgp-1/CD44 has been extensively used as a marker to distinguish
precursors, subsets and memory cells in the T lymphocyte lineage (12, 26, 28) .
More recently, identity between Pgp-1/CD44 and the Hermes class of molecule
in humans was appreciated (8) . The latter is thought to be involved in lymphocyte
TABLE I
Antibodies to Pgp-I Do Not Influence Factor-dependent Colony
Formation by Bone Marrow Cells
Antibodies were added to three different colony assays at final concentrations
of 25 ,ug/ml . Colonies were counted on day 6 (IL-7) or day 7 ((WEHI-3, LCCM) .
The number of colonies without stimulation was always <2, irrespective of ad-
dition ofantibodies . Values are presented as means t standard error for quad-
ruplicate cultures .
Antibodies IL-7
No . of colonies/10 5 cells
WEHI-3
elicited by
LLCM
None 405 t 32 203 t 6 192 t 20
KM 201 379 t 57 195 t 13 213 t 10
IM 7 .8 .1 371 t 20 210 t 16 189 t 11
M17/4.2(aLFA-1) 410 t 34 213 t 16 194 f 5
MEL14 407 1 31 210 7 186 1 9
14.8 359 t 25 192 t 18 187 ± 16MIYAKE ET AL.
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recognition ofhigh endothelial venules and the resultingeffects on lymphocyte migra-
tion (29). There are also indications that Pgp-1 might participate in recognition of
extracellular matrix components (10, 30, 31), and it is thought to be a transmem-
braneprotein intimately associated with thecytoskeleton (30, 31). Molecularcloning
of Pgp-1 has now been achieved and this revealed structural homology between one
of its N112-terminal domains and a proteoglycan link protein (21, 32). Although the
mAb MEL-14 raised to murine cells recognizes human Pgp-1/CD44, the murine
gene is unrelated (8, 21, 32-34). This is consistent with the finding that MEL-14
did not inhibit murine long-term cultures. Perhapsthis molecule is more important
for interactions between cells in peripheral lymphoid tissues than those that occur
within bone marrow.
Attention can now be focused on mechanisms through which antibodies to Pgp-
I/CD44 inhibit long-term cultures. Direct toxicity to hemopoietic progenitors seems
unlikely because much higher concentrations of antibodies had no effect on IL-7-
dependent and CSF-dependent cloning assays done with semisolid agar. It remains
possible that cell-mediated cytotoxicity with passively acquired antibodies is impor-
tant for eliminationofcritical cell types in thelong-term cultures. However, marked
agglutination of myeloid cells in culture by MEL-14 and LFA-1 antibodies did not
prevent emergence of hemopoieticcells. The presence ofLFA-1 hasbeen documented
on a variety of hemopoietic precursors (6). Moreover, these two antibodies are of
the same IgG2a isotype as KM 703, which is completely suppressive. Additional
studies involving fragmented or immobilized antibodies may be informative in this
regard. Similarly, while theadherent layers of treated cultures were not grossly affected,
more subtle effects on the microenvironment can now be explored with cloned cell
lines and different treatment protocols. One previous study revealed no influence
of Pgp-1 antibodies on fibroblast growth or morphology (30). Stromal cellselaborate
anumber of cytokines (3)and effects of antibody treatmenton this parameter should
also be investigated.
It is probable that adhesive interactions are important for lympho-hemopoietis
in LTBMC. Indeed, preferential associations between precursors and stromal cells
have been documented in previous studies (35, 36). Our new mAbs to Pgp-1 were
selected on the basis of their ability to inhibit adhesion of a B lineage hybridoma
cell to a cloned stromal cell line and flow cytometric analyses revealed that the an-
tigen is expressed in relatively high density on both cell types. However, additional
studies are required to determine if inhibition of close cellular interactions by anti-
Pgp-I/CD44 antibodies accounts fortheir effects in long-termcultures. Theresulting
informationmaybe informative about vitalfunctionsmediated by the Pgp-1 molecule.
Summary
A new panel of mAbs was prepared to a stromal cell line known to support lym-
phocytes in Whitlock-Witte type long-term bone marrow cultures. Theseantibodies
were then screened with a cell adhesion assay and four were selected that inhibited
the binding of B lineage cells to stromal cell monolayers. Immunofluorescent and
biochemical analyses revealed that these newantibodies detected epitopes of the pre-
viously described Pgp-1/CD44 antigen complex. Addition of Pgp-1/CD44 antibodies
to Dexter-type long-term bone marrow cultures completely prevented emergence
of myeloid cells and they also blocked lymphocyte growth in Whitlock-Witte type486
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cultures. mAbs MEL-14, LFA-1, and CD45R did not inhibit under the same condi-
tions and there was no apparent relationship to Ig isotype. Adherent layers in treated
cultures were not unusual in terms of morphology and the antibodies did not affect
factor-dependent replication of lymphoid or myeloid progenitor cells. Therefore,
the mechanism of inhibition may not involve direct toxicity to precursorsor microen-
vironmental elements. Previous studies in humans and mice have implicated Pgp-
1/CD44-related glycoproteins in the migration of peripheral lymphoid cells, as well
as interactions of cells with the extracellular matrix. These findings suggest that they
may also be critical for formation oflymphoid and myeloid cells within bone marrow.
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